@article{d918372d83424f23ae2a522c189aa1b2,
title = "Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus",
keywords = "Droxidopa, Neurogenic orthostatic hypotension, Parkinson disease, Type 2 diabetes mellitus",
author = "Steven Vernino and Daniel Claassen",
note = "Funding Information: Conflict of interest Dr. Vernino has served as a consultant for Athena Diagnostics, and on advisory boards and speaker bureaus for Lundbeck. Dr. Claassen has received research grants from NIH/NINDS, Michael J. Fox Foundation, Vaccinex, CHDI, C2 N, and Auspex, and he is a consultant for Teva Neuroscience, Lundbeck, Acadia, and AbbVie.",
year = "2017",
month = jul,
day = "1",
doi = "10.1007/s10286-017-0435-5",
language = "English (US)",
volume = "27",
pages = "33--34",
journal = "Clinical Autonomic Research",
issn = "0959-9851",
publisher = "D. Steinkopff-Verlag",
}